PW Medtech Group Limited — Board/Management Information 2021

Jul 30, 2021

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

PW MEDTECH GROUP LIMITED 普 華 和 順 集 團 公 司

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 1358)

CHANGE OF INDEPENDENT NON-EXECUTIVE DIRECTOR, REMUNERATION COMMITTEE MEMBER AND NOMINATION COMMITTEE MEMBER

The Board announces Mr. Zhang Xingdong has resigned and Ms. Wang Fengli has been appointed as an independent non-executive director and a member of remuneration committee and a member of nomination committee of the Board with effect from 1 August 2021.

RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND A MEMBER OF BOTH THE REMUNERATION COMMITTEE AND NOMINATION COMMITTEE

The board of directors (the ‘‘Board’’) of PW Medtech Group Limited (the ‘‘Company’’) announces that Mr. Zhang Xingdong (‘‘Mr. Zhang’’) has resigned as an independent non-executive director and a member of both the Remuneration Committee and Nomination Committee of the Company with effect from 1 August 2021 due to his retirement.

Mr. Zhang has confirmed that he has no disagreement with the Board and there is no matter relating to his resignation that needs to be brought to the attention of the shareholders of the Company.

The Board would like to take this opportunity to express its sincere gratitude to Mr. Zhang for his valuable contributions to the Company.

APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND A MEMBER OF BOTH THE REMUNERATION COMMITTEE AND NOMINATION COMMITTEE

The Board also announces that Ms. Wang Fengli (‘‘Ms. Wang’’) has been appointed as an independent non-executive director and a member of both the Remuneration Committee and Nomination Committee of the Company with effect from 1 August 2021.

– 1 –

The biographical details of Ms. Wang are set out as follows:

Ms. Wang, aged 58, graduated from Northwest University of Political Science and Law (西北政法大 學) with a Master’s degree in Law in March 2006. She also graduated from Sichuan University with a Bachelor’s degree in History in July 1985.

Ms. Wang has worked in Northwest University of Political Science and Law starting from July 1985, and (i) served as an assistant teacher in the teaching research section of the Party History (黨史教研室) of Department of the Theory (理論系) of Northwest Institute of Politics and Law (西北政法學院) (now known as Northwest University of Political Science and Law) from July 1985 to December 1986; (ii) served as a lecturer in the teaching research section of the Party History of Department of the Theory of Northwest Institute of Political Science and Law from January 1987 to December 1991; (iii) was an associate professor and head of teaching research section of International Trade (國際貿易教研室) in the Department of Business Trading (經貿系) of Northwest University of Political Science and Law from January 1992 to December 2001; (iv) served as a professor in the Department of International Trade (國際貿易系) of the School of Economics (經濟學院) of Northwest University of Political Science and Law since December 2011; and (v) served as head of the Department of International Trade from December 2011 to December 2016. Ms. Wang currently serves as a professor in the Department of International Trade of the School of Economics of Northwest University of Political Science and Law as well as the person-in-charge of the programme of Master degree for International Commerce (國際商務專業) and is engaged in the teaching and research of International Commerce.

Ms. Wang has been providing training in business negotiation and business etiquette for various enterprises, and has published five master works and more than 30 relevant essays. Ms. Wang obtained the Education Certificate of Independent Director qualification (獨立董事資格教育證書) of Shenzhen Stock Exchange in August 2015. She was an independent director of Sunresin New Materials Co., Ltd, Xi’An. (西安藍曉科技新材料股份有限公司) (a company listed on the Shenzhen Stock Exchange, stock code: 300487) from 2015 to April 2021.

Save as disclosed above, Ms. Wang has not held other directorships in the last three years in public companies the securities of which are listed on any securities market in Hong Kong or overseas.

The Company has issued a letter of appointment to Ms. Wang for a term of office of 3 years from 1 August 2021, unless terminated by either party giving to the other not less than 3 months’ prior notice in writing. She is also subject to retirement by rotation and re-election at the annual general meeting of the Company in accordance with the Company’s articles of association.

As far as the directors of the Company are aware, as at the date of this announcement, Ms. Wang does not have any relationships with other directors, senior management, substantial shareholders (as defined in the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the ‘‘Listing Rules’’)), or controlling shareholders (as defined in the Listing Rules) of the Company.

– 2 –

As far as the directors of the Company are aware, as at the date of this announcement, Ms. Wang was not interested or deemed to be interested in any shares or underlying shares of the Company or its associated corporations pursuant to Part XV of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong).

Ms. Wang is entitled to an annual director’s fee of HK$200,000 pursuant to the letter of appointment, which has been determined with reference to her role and duties, as well as the prevailing market conditions. She is also eligible to participate in the Company’s share option schemes. The emoluments of Ms. Wang are subject to revision in future by the decision of the Board based on the recommendation of the remuneration committee of the Company.

As far as the directors of the Company are aware, there is no information of Ms. Wang to be disclosed pursuant to any of the requirements under paragraphs 13.51(2)(h) to 13.51(2)(v) of the Listing Rules; and there are no other matters concerning Ms. Wang that need to be brought to the attention of the shareholders of the Company.

The Board would like to extend a warm welcome to Ms. Wang for joining the Board.

By Order of the Board

PW Medtech Group Limited Yue’e Zhang Chairman & Chief Executive Officer

Hong Kong, 30 July 2021

As at the date of this announcement, the Board comprises one executive director, namely, Ms. Yue’e Zhang; two non-executive directors, namely, Mr. Lin Junshan and Mr. Jiang Liwei; and three independent non-executive directors, namely, Mr. Chen Geng, Mr. Wang Xiaogang and Mr. Zhang Xingdong.

– 3 –